34th week of 2020 patent applcation highlights part 22 |
Patent application number | Title | Published |
20200262736 | METHOD OF PRODUCING OPTICAL FIBER PREFORM AND OPTICAL FIBER - A method of producing an optical fiber preform includes a silica glass body forming step of forming a silica glass body to be at least a portion of a core portion. The method includes an alkali-metal-doped silica glass body forming step of forming an alkali-metal-doped silica glass body doped with an alkali metal around the silica glass body such that the alkali-metal-doped silica glass body contacts the silica glass body. The method further includes a diffusing step of diffusing the alkali metal from the alkali-metal-doped silica glass body to the silica glass body by a heat treatment. | 2020-08-20 |
20200262737 | Enhanced Particle Deposition System and Method - A deposition system for depositing a chemical vapor onto a workpiece is disclosed, including a deposition chamber having a plurality of components for performing chemical vapor deposition on the workpiece. The workpiece is held by a lathe that rotates the workpiece relative to chemical burners that deposit silica soot on the workpiece. The deposition system has a gas panel for regulating the flow of gases and vapors into the deposition chamber, and a computer for controlling operation of the gas panel and the components in the deposition chamber. Multiple sets of chemical burners are disposed longitudinally along the length of the workpiece. Each set of burners is separated from other sets, such that each set of burners deposit silica particles onto generally different portions of a workpiece. The respective portions include an overlap segment in which one or more burners from one burner set will deposit silica particles on the same portion of the workpiece as one or more burners from another set. | 2020-08-20 |
20200262738 | Fluorescent Glass Ceramics And Glasses With Cerium And Tin Content - The invention relates to glass ceramics and glasses with cerium and tin content, which comprise the following components: | 2020-08-20 |
20200262740 | COLORED WATCH GLASS - A transparent timepiece component, in particular a watch glass, has a substantially planar or curved interior surface, and has mainly a transparent material colored by a zone of modified chemical composition within the component through an introduction of at least one coloring chemical element of the transparent material, this zone of modified chemical composition extending in one part only of the total thickness of the timepiece component. | 2020-08-20 |
20200262741 | CONDUCTIVE PASTE FOR SOLAR CELL ELECTRODE, AND SOLAR CELL MANUFACTURED USING SAME - The present invention relates to a conductive paste for a solar cell electrode, comprising: a metal powder; glass frit; and organic vehicles, wherein the glass frit includes a first glass frit having a first glass transition temperature and a second glass frit having a second glass transition temperature that is higher than the first glass transition temperature, wherein the glass frit is contained in an amount of 1-10% by weight with respect to the total weight of the paste, the content of the first glass frit being larger than that of the second glass frit. The present invention can improve the conversion efficiency and adhesion characteristics of a solar cell by using two or more kinds of glass frits having different glass transition temperatures in combination. | 2020-08-20 |
20200262742 | MICRO-PERFORATED PANEL SYSTEMS, APPLICATIONS, AND METHODS OF MAKING MICRO-PERFORATED PANEL SYSTEMS - The described embodiments relate generally to a micro-perforated panel systems and methods for noise abatement and method of making a micro-perforated panel system. In particular, embodiments relate to glass micro-perforated panel systems and methods for their construction. | 2020-08-20 |
20200262743 | HIGH-STRENGTH ANTI-FINGERPRINT GLASS, PREPARATION METHOD THEREOF, EXTERIOR PART OF HIGH-STRENGTH ANTI-FINGERPRINT GLASS, AND PREPARATION METHOD THEREOF - High-strength anti-fingerprint glass includes a glass base material. The glass base material includes a first surface and a second surface that are provided opposite to each other, at least one of the first surface and the second surface is provided with a micro-texture structure, the micro-texture structure includes a plurality of micro-texture units, an orthographic projection area of each micro-texture unit on the first surface or the second surface ranges from 0.0004 mm | 2020-08-20 |
20200262744 | DEADFRONT FOR DISPLAYS INCLUDING A TOUCH PANEL ON DECORATIVE GLASS AND RELATED METHODS - Embodiments of a deadfront article are provided. The deadfront article includes a substrate having a first surface and a second surface. The deadfront article also includes a semi-transparent layer disposed onto the second surface of the substrate. The semi-transparent layer has a region of a solid color or of a design of two or more colors, and the semi-transparent layer has a first optical density. Further, the deadfront article includes a contrast layer disposed onto the region. The contrast layer is configured to enhance visibility of the color(s) of the semi-transparent layer. | 2020-08-20 |
20200262745 | TRANSPARENT SUBSTRATES COMPRISING THREE-DIMENSIONAL POROUS CONDUCTIVE GRAPHENE FILMS AND METHODS FOR MAKING THE SAME - Disclosed herein are graphene coatings characterized by a porous, three-dimensional, spherical structure having a hollow core, along with methods for forming such graphene coatings on glasses, glass-ceramics, ceramics, and crystalline materials. Such coatings can be further coated with organic or inorganic layers and are useful in chemical and electronic applications. | 2020-08-20 |
20200262746 | PROTECTIVE COVER, ITS USE AND METHOD OF MAKING A PROTECTIVE COVER - The present disclosure relates to a protective cover including at least one transparent inorganic layer and at least one transparent adhesion layer. The transparent inorganic layer may include glass or glass ceramic. In a preferred embodiment, the inorganic layer is glass or glass ceramic. In an embodiment, the protective cover further includes a polymer layer disposed between the inorganic layer and the adhesion layer. | 2020-08-20 |
20200262747 | Solar Control Coatings With Subcritical Copper - A coated article includes a substrate, a first dielectric layer, a subcritical metallic layer having discontinuous metallic regions, a primer over the subcritical layer, and a second dielectric layer over the primer layer. The primer can be a nickel-chromium alloy. The primer can be a multilayer primer having a first layer of a nickel-chromium alloy and a second layer of titania. The subcritical layer can contain copper and silver. | 2020-08-20 |
20200262748 | METHOD OF MAKING A REFLECTIVE COATED GLASS ARTICLE - A method of making a reflective coated glass article includes providing a glass substrate. A first gaseous mixture is formed. The first gaseous mixture includes a silane compound and inert gas. The first gaseous mixture is delivered to a location above a major surface of the glass substrate to deposit a first coating layer directly on the major surface of the glass substrate. The first coating layer is deposited at a thickness of 5-50 nm. A second gaseous mixture is formed. The second gaseous mixture includes a silane compound, a radical scavenger and molecular oxygen. The second gaseous mixture is delivered to a location above the first coating layer. A second coating layer is deposited at a thickness of 5-50 nm over the first coating layer. The coated glass article exhibits a total visible light reflectance (Illuminant D65, ten degree observer) of 45% or more from a coated side of the coated glass article. | 2020-08-20 |
20200262749 | RESIN COMPOSITION AND OPTICAL FIBER - A resin composition includes a base resin containing a urethane (meth)acrylate oligomer, a monomer having a phenoxy group, a photopolymerization initiator, and a silane coupling agent and hydrophobic inorganic oxide particles, wherein the content of the inorganic oxide particles is 1% by mass or more and 45% by mass or less based on the total amount of the resin composition. | 2020-08-20 |
20200262750 | GLASS PANEL AND GLASS WINDOW - An object is to enable suppression of thermal leakage at a peripheral portion of a pair of glass plates disposed so as to be opposed to each other with a gap interposed therebetween. A pair of glass plates | 2020-08-20 |
20200262751 | MANUFACTURING A BINDER WITH HIGH B BELITE CONTENT - The present invention relates to a method for manufacturing a binder with high β belite content comprising the steps:
| 2020-08-20 |
20200262752 | HYALOCLASTITE POZZOLAN, HYALOCLASTITE BASED CEMENT, HYALOCLASTITE BASED CONCRETE AND METHOD OF MAKING AND USING SAME - The invention comprises a composition comprising hyaloclastite having a volume-based mean particle size of less than or equal to 40 μm. The invention also comprises a cementitious material comprising a hydraulic cement and hyaloclastite, wherein the hyaloclastite has a volume-based mean particle size of less than or equal to approximately 40 μm. The invention further comprises a cementitious-based material comprising aggregate, a cementitious material comprising a hydraulic cement and hyaloclastite, wherein the hyaloclastite has a volume-based mean particle size of less than or equal to approximately 40 μm and water sufficient to hydrate the cementitious material. A method of using the composition of the present invention is also disclosed. | 2020-08-20 |
20200262753 | ELECTRICALLY CONDUCTIVE CONCRETE COMPOSITION AND SYSTEM DESIGN FOR RESISTIVE HEATING OF PAVEMENTS WITH LOW VOLUME FRACTIONS OF CARBON MICROFIBER - The present application relates to a concrete pre-mix composition comprising a cementitious material and a plurality of conductive carbon microfibers mixed with said cementitious material, where said conductive carbon microfibers are present in the concrete pre-mix composition in an amount such that, when said concrete pre-mix composition is hydrated to form concrete and cured, the conductive carbon microfibers are dispersed in the cured concrete in an amount of 0.75% to 2.00% of total mass of the concrete. The present application further relates to a concrete composition, a method of producing an electrically conductive concrete composition, an electrically conductive cured concrete form, and a system for heating pavement. | 2020-08-20 |
20200262754 | System and Method for Pre-Treatment of Rubber-Modified Asphalt Cement, and Emulsions Thereof - This invention encompasses asphalt cement emulsions, as well as methods for preparing a pre-treated rubber-modified asphalt cement emulsions and methods for coating industrial surfaces using asphalt cement emulsions. | 2020-08-20 |
20200262755 | DURABLE CONCRETE WITH CHEMICALLY LINKED CEMENT - A composition of matter has cement particles and resin structures having: a first functional group bonded directly to a surface of each cement particle; and a second functional group that bonds to calcium silicate hydrate upon hydration, wherein the second functional group is bondable with second functional groups of others of the cement particles to form a polymer network; and a backbone that connects the first functional group with the second functional group. A method of forming cement particles includes mixing cement particles with reactive molecules, the reactive molecules having a first functional group bonded directly to a surface of each cement particle, a second functional group that is bondable to calcium silicate hydrate upon hydration, wherein the second functional group is bondable with second function groups of others of the cement particles to form a polymer network, and a backbone that connects the first functional group with the second functional group. A composition of matter has cement particles, and a cured resin structure resulting from a reaction between two or more reactive molecules having functional groups that react with each other onto the surfaces of the cement particle, wherein one of the reactive molecules is used in less than a stoichiometric amount, leaving unreacted functional groups, and wherein the unreacted functional groups are bondable to calcium silicate hydrate upon hydration. | 2020-08-20 |
20200262756 | Method for the Production of Gypsum-Based Boards and Stucco Slurry Comprising Non-Pregelatinized Migratory Starch for Use Therewith - A method for continuously forming gypsum-based panels of high fixing strength comprises the steps of: •forming a mixture comprising stucco, non-pregelatinized migratory starch, glass fibre, fluidizer and water; •casting the mixture in a continuous band; •maintaining the band under conditions sufficient for the stucco to form an interlocking matrix of set gypsum; •cutting the band to form one or more wet panel precursors; and •drying the wet panel precursor to form one or more gypsum-based panels. •The weight ratio of water to stucco in the mixture is less than 0.7; •the stucco is present in the mixture in an amount of over 60 wt % relative to the total solids content of the mixture; •the starch is present in the mixture in an amount of over 3 wt % relative to the the stucco; •the glass fibre is present in the mixture in an amount of over 1 wt % relative to the stucco; •the fluidizer is is present in the mixture in an amount of at least 0.1 wt % relative to the stucco; and the density of the gypsum-based panel is greater than 700 kg/m. | 2020-08-20 |
20200262757 | OZONATION-BASED METHOD FOR PRODUCING CEMENTITIOUS MATERIAL - An ozonation-based method for producing a cementitious material comprises the steps of: (1) mixing a flue gas with an ozone-containing gas to form a mixed flue gas; and introducing the mixed flue gas into an absorption tower, where the mixed flue gas undergoes dry desulfurization and denitrification by reacting with a powdered desulfurizing and denitrificating agent and becomes a treated flue gas; (2) subjecting the treated flue gas to dust removal to generate by-products; and (3) uniformly mixing raw materials that comprise the first by-product, magnesium oxide, fly ash and an additive to give a cementitious material, wherein on the basis of 100 parts by weight of the cementitious material, the first by-product is 20-60 parts by weight, magnesium oxide is 16-33 parts by weight, the fly ash is 15-35 parts by weight, and the additive is 1-15 parts by weight. | 2020-08-20 |
20200262758 | METHOD FOR PRODUCING INSULATING MATERIAL OR AN INSULATING PRODUCT FOR THE REFRACTORY INDUSTRY, CORRESPONDING INSULATING MATERIALS AND PRODUCTS, AND USES - What are described are a process for producing an insulating product for the refractory industry or an insulating material as intermediate for production of such a product, and a corresponding insulating material/insulating product. Likewise described are the use of a matrix encapsulation process in the production of an insulating product for the refractory industry and a corresponding insulating product and/or an insulating material as intermediate for production of such a product. | 2020-08-20 |
20200262759 | PINK ZIRCONIA SINTERED BODY AND MANUFACTURING METHOD OF THE SAME - A zirconia sintered body comprising 3.0 wt % or more and 30.0 wt % or less of aluminum in terms of Al | 2020-08-20 |
20200262760 | Composition, Film, and Method for Producing Film - A composition including a binder and a variable thermal conductivity material satisfying a conditional expression 1, wherein a content of the variable thermal conductivity material is from 300 parts by weight to 10,000 parts by weight with respect to a content of 100 parts by weight of the binder: | 2020-08-20 |
20200262761 | SUPERHARD CONSTRUCTIONS & METHODS OF MAKING SAME - A super hard polycrystalline construction has a first region having a body of thermally stable polycrystalline super hard material with an exposed surface forming a working surface, and a peripheral side edge, a second region forming a substrate to the first region and a third region interposed between the first and second regions. The third region extends across a surface of the second region along an interface and has a composite material having a first phase comprising a plurality of non-intergrown diamond grains, the majority of the diamond grains having a coating comprising nano-sized BN particles. There is also disclosed a method of making such a construction. | 2020-08-20 |
20200262762 | SYSTEMS AND METHODS FOR PRODUCING A CARBON COMPOSITE MATERIAL - A carbon/carbon brake disk is provided. The carbon/carbon brake disk may comprise a carbon fiber, wherein the carbon fiber is formed into a fibrous network, wherein the fibrous network comprises carbon deposited therein. The carbon fiber may undergo a FHT process, wherein micro-cracks are disposed in the carbon fiber. In various embodiments, the micro-cracks may be at least partially filled with un-heat-treated carbon via a final CVD process, wherein the final CVD process is performed at a temperature in the range of up to about 1,000° C. (1,832° F.) for a duration in the range from about 20 hours to about 100 hours. In various embodiments, the un-heat-treated carbon may be configured to prevent oxygen, moisture, and/or oxidation protection systems (OPS) chemicals from penetrating the carbon/carbon brake disk. In various embodiments, the final CVI/CVD process may be configured to increase the wear life of the carbon/carbon brake disk. | 2020-08-20 |
20200262763 | POULTRY LITTER-BASED FERTILIZER AND A METHOD FOR MAKING THE POULTRY LITTER-BASED FERTILIZER FROM POULTRY LITTER - A method for producing a poultry litter-based fertilizer by a) supplying poultry litter to a rotating rotary drum, b) adding acid or a source of acid to the rotating rotary drum, wherein acid reacts with the poultry litter to form an acidified mixture, c) adding ammonia or a source of ammonia to the rotating rotary drum, d) drying and cooling the ammoniated product by evaporation of water to form a dried, cooled product in a free-flowing semi-solid or solid form, repeating the steps b) through d) until a desired nitrogen content is reached in the dried, cooled product. | 2020-08-20 |
20200262764 | PLANT GROWTH PROMOTER - The present invention is a plant growth promoter containing a lignocellulosic biomass, wherein the lignocellulosic biomass has a lignin content of 40% by mass or more and 60% by mass or less and a contact angle with water of 50° or less. | 2020-08-20 |
20200262765 | PRODUCTION OF NUTRIGEL MATERIALS FROM SOYA WASTE - Disclosed herein are superabsorbent hydrogels formed using okara particles and polymeric chains. The hydrogel contains crosslinks, which are provided by crosslinking groups between the polymeric chains or by a plurality of polymer chains being bonded to each okara particle (with each of these chains being bonded to at least one further okara particle too). The resulting superabsorbent hydrogels are useful in aiding plant growth, nutrition and hydration, and may be mixed with soil to form a composite material for such purposes. | 2020-08-20 |
20200262766 | COATED GRANULAR FERTILIZERS, METHODS OF MANUFACTURE THEREOF, AND USES THEREOF - A coated fertilizer comprising a fertilizer granule and a coating disposed on a surface of the fertilizer granule, wherein the coating comprises interpenetrating domains comprising polymer domains and wax domains. A method of making the coated fertilizer is also disclosed. | 2020-08-20 |
20200262767 | Method of Olefin Oligomerization - The present invention relates to a method for olefin oligomerization, and can provide a method for olefin oligomerization. The method includes the steps of: introducing an oligomerization transition metal catalyst, olefin monomers, and a solvent into a reactor and performing an olefin oligomerization reaction to produce an oligomer; introducing a catalyst deactivator to a reaction product of the oligomerization reaction to deactivate the catalyst, with the catalyst deactivator including at least one functional group containing at least one selected from the group including oxygen, phosphor, nitrogen, and sulfur and having a number average molecular weight of 400 or more; separating the oligomer through distillation in a distiller; and separating the catalyst deactivator through the bottom end of the distiller. | 2020-08-20 |
20200262768 | INTEGRATED PROCESS FOR MAXIMIZING PRODUCTION OF PARA-XYLENE FROM FULL REFORMATE - A method of producing p-xylene, the method comprising the steps of converting the C9+ aromatic hydrocarbons and the hydrogen gas in the presence of a dealkylation catalyst to produce a dealkylation effluent, separating the dealkylation effluent to produce a carbon-nine (C9) aromatics stream, a xylene stream, and a toluene stream, separating the p-xylenes from the xylene stream in the p-xylene separation unit to produce a p-xylene product and a p-xylene depleted stream, converting the m-xylene and o-xylene in the p-xylene depleted stream in the isomerization unit to produce an isomerization effluent, reacting the C9 aromatics stream and the hydrogen stream in the presence of a transalkylation catalyst in the transalkylation reactor to produce a transalkylation effluent, separating the C6 to C9+ aromatic hydrocarbons in the isomerization effluent and the transalkylation effluent in the splitter column to produce a benzene recycle, a toluene recycle, a xylene recycle and a C9+ recycle. | 2020-08-20 |
20200262769 | Method for Preparing Hexadecahydropyrene - A method for preparing hexadecahydropyrene includes the step of carrying out the hydrogenation reaction to hydrocarbon oil containing pyrene compounds in the presence of a hydrogenation catalyst. The pyrene compounds are selected from at least one of pyrene and unsaturated hydrogenation products thereof. The hydrogenation catalyst contains a carrier and an active metal component loaded on the carrier. The active metal component is Pt and/or Pd and the carrier contains a small crystal size Y zeolite, alumina and amorphous silica-alumina. The small crystal size Y zeolite has an average grain diameter of 200-700 nm, a molar ratio of SiO | 2020-08-20 |
20200262770 | Process for the Manufacture of Fluoroaryl Compounds and Derivatives - The invention relates to a new process for the manufacture of fluoroaryl compounds and derivatives thereof, in particular of fluorobenzenes and derivatives thereof, and especially wherein said manufacture relates to an environmentally friendly production of the said compounds. Thus, the present invention overcomes the disadvantages of the prior art processes, and in a surprisingly simple and beneficial manner, and as compared to the prior art processes, in particular, the invention provides a more efficient and energy saving processes, and also provides a more environmentally friendly process, for the manufacture of nuclear fluorinated aromatics, and preferably of nuclear fluorinated fluorobenzenes. Accordingly, in one aspect of the invention, an industrially beneficial process for preparing fluorobenzenes from halobenzene precursors using HF to form hydrogen halide is provided by the present invention. A beneficial and surprisingly simple use of chlorobenzene as an industrially interesting starting material in the manufacture of fluorobenzene is provided. | 2020-08-20 |
20200262771 | ONE STEP PROCESS FOR MANUFACTURING TRIFLUOROIODOMETHANE FROM TRIFLUOROACETYL HALIDE, HYDROGEN, AND IODINE - The present disclosure provides a process for producing trifluoroiodomethane (CF | 2020-08-20 |
20200262772 | RECOVERY OF ETHYL HEXANOL FROM RECYCLE STREAMS IN 2-ETHYL HEXANOL PROCESS - A method of recovering 2-ethyl hexanol (2-EH) from crude alcohol that includes the 2-ethyl hexanol, 2-ethyl, 3-propyl acrolein (EPA), and 2-ethylhexanal (EHA) is disclosed. The crude alcohol stream is first separated into a first stream of primarily 2-EH, a second stream of primarily EPA and 2-EH collectively, and a third stream of primarily 2-EH and EHA collectively. The second stream and the third stream are combined to form a combined stream. The combined stream is processed further to form a first product stream comprising primarily 2-EH and a second product stream comprising primarily, 2-EH, EHA, and EPA collectively. | 2020-08-20 |
20200262773 | PROCEDURE FOR CRYSTALLIZATION OF (22E)-(24R)-2-METHYLENE-22-DEHYDRO-1A,24-25-TRIHYDROXY-19-NOR-VITAMIN D3 - Disclosed are methods of purifying the compound (22E)-(24R)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D | 2020-08-20 |
20200262774 | PROCESS - A process for dehydrating methanol to dimethyl ether product in the presence of an aluminosilicate zeolite catalyst and a promoter selected from (i) aldehyde of formula R | 2020-08-20 |
20200262775 | Process for Friedel-Crafts Reaction, and Catalyst Therefore - The invention relates to a new process for the manufacture of fluoroaryl compounds and derivatives thereof, in particular of fluorobenzenes and derivatives thereof, and especially wherein said manufacture relates to an environmentally friendly production of the said compounds. Thus, the present invention overcomes the disadvantages of the prior art processes, and in a surprisingly simple and beneficial manner, and as compared to the prior art processes, in particular, the invention provides a more efficient and energy saving processes, and also provides a more environmentally friendly process, for the manufacture of nuclear fluorinated aromatics, and preferably of nuclear fluorinated fluorobenzenes. Accordingly, in one aspect of the invention, an industrially beneficial process for preparing fluorobenzenes from halobenzene precursors using HF to form hydrogen halide is provided by the present invention. A beneficial and surprisingly simple use of chlorobenzene as an industrially interesting starting material in the manufacture of fluorobenzene is provided. | 2020-08-20 |
20200262776 | New Process for the Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof - The invention relates to a new process for the manufacture or synthesis, respectively, of fluorinated benzenes and fluorinated benzophenones, and derivatives thereof, in particular of fluorobenzenes and derivatives thereof. The present invention particularly pertains to a novel environmentally friendly process for the synthesis of fluorinated benzenes and benzophenones as raw materials for the manufacture of polyaryletherketones (PAEKs). | 2020-08-20 |
20200262777 | METHOD FOR PREPARING HYDROXYBENZOPHENONE POLYGLYCOL ETHER (METH)ACRYLATE - A method for preparing hydroxybenzophenone polyglycol ether (meth)acrylate comprising the steps of
| 2020-08-20 |
20200262778 | PROCESS FOR PRODUCTION OF ALLYL ALCOHOL - The invention relates to a process for producing allyl alcohol, the process comprising:
| 2020-08-20 |
20200262779 | PROCESS FOR MAKING ALICYCLIC POLYCARBOXYLIC ACIDS OR THEIR DERIVATIVES - The present invention discloses a process for making alicyclic polycarboxylic acids or their derivatives, referring to a process for hydrogenating aromatic polycarboxylic acids or their derivatives in the presence of hydrogen and a catalyst to form alicyclic polycarboxylic acids or their derivatives, and the catalyst comprises at least one active metal of group VIIIB transition elements of the periodic table of elements, and a catalyst support comprising group IIA and group IIIA elements in a specific weight ratio. | 2020-08-20 |
20200262780 | SOLVENT COMPOUNDS FOR USE AS GLYCOL ETHER REPLACEMENTS - The present disclosure provides, in part, a solvent compound for use as a substitute for a glycol ether, an alkyl ether of diethylene glycol, ethylene glycol or propylene glycol. | 2020-08-20 |
20200262781 | Method for the Preparation of 4-(Heptafluoro-2-Propyl) Anilines - The invention discloses a method for the preparation of substituted 4-(heptafluoro-2-propyl) anilines by reaction of 2-bromoheptafluoropropane with anilines in the presence of sodium dithionite, in a solvent and in the presence of a catalyst. | 2020-08-20 |
20200262782 | Diamine Compound, and Polyimide Compound and Molded Product Using the Same - [Problems to be solved] The present invention provides a novel diamine compound which allows for the synthesis of a polyimide compound having a high solubility in an organic solvent and a high melt moldability. | 2020-08-20 |
20200262783 | Diamine Compound, and Polyimide Compound and Molded Product Using the Same - [Problems to be Solved] The present invention provides a novel diamine compound which allows for the synthesis of a polyimide compound having a high solubility in an organic solvent and a high melt moldability. | 2020-08-20 |
20200262784 | TRIFLUOROMETHOXYLATION OF ARENES VIA INTRAMOLECULAR TRIFLUOROMETHOXY GROUP MIGRATION - The present invention provides a process of producing a trifluoromcthoxylated aryl or trifluoromothoxylated heteroaryl having the structure: | 2020-08-20 |
20200262785 | 2-CYANO-2-FLUOROETHENOLATE SALTS (CFES): VERSITILE ACTIVE PHARMACEUTICAL INTERMEDIATES - The present invention relates to new enolate structures with utility as active pharmaceutical intermediates for the preparation of efficacious drugs such as those derived from 5-fluorocytosine (5-FC). | 2020-08-20 |
20200262786 | NOVEL INTERMEDIATE COMPOUND FOR MANUFACTURING BIXIN ETHYL ESTER AND METHOD OF MANUFACTURING THE SAME - The present invention relates to a method of manufacturing norbixin or bixin ethyl ester, which is a carotenoid-based compound, from a novel intermediate compound. When the novel intermediate compound is used, it is possible to manufacture norbixin or bixin ethyl ester in high yield through a simple process. | 2020-08-20 |
20200262787 | OPTICAL COMPONENT FORMING COMPOSITION AND CURED PRODUCT THEREOF - The present invention provides an optical component forming composition comprising a tellurium-containing compound or a tellurium-containing resin. | 2020-08-20 |
20200262788 | PROCESS FOR PREPARATION OF MOLINDONE - The present invention provides process for preparation of molindone (I) comprising: a) reacting compound with cyclohexane-1,3-dione to form 2-(2-oxopentan-3-yl)cyclohexane-1,3-dione wherein X is Cl, Br or I, b) cyclizing 2-(2-oxopentan-3-yl)cyclohexane-1,3-dione to 2-methyl-3-ethyl-4-oxo-4,5,6,7-tetrahydroindole, c) reacting 2-methyl-3-ethyl-4-oxo-4,5,6,7-tetrahydroindole with morpholine and formaldehyde to give molindone (I), and d) optionally converting molindone (I) to its salt. The present invention further provides process for preparation of compound comprising: a) reacting compound with ethyl halide and another halide source to form compound wherein R is alkyl and X is Cl, Br or I; b)converting compound to compound. | 2020-08-20 |
20200262789 | METHODS OF PRODUCING MOLINDONE AND ITS SALTS - The present invention is directed towards novel methods of synthesis of molindone, synthesis of the intermediates of molindone, and high-purity compositions of molindone. In particular, the invention relates to the methods of synthesis of molindone through the Mannich reaction. | 2020-08-20 |
20200262790 | PREPARATION METHOD OF N-SUBSTITUTED DIBENZO[A,C]CARBAZOLE COMPOUND - Pharmaceutical and chemical intermediates and relevant chemicals, and relates to a novel preparation method of N-substituted dibenzo[a,c]carbazole compound. O-alkynylaniline and derivatives thereof as raw materials conduct a cascade cyclization reaction in an anhydrous organic solvent in the presence of catalysts, oxidants and additives, and are converted into the N-substituted dibenzo[a,c]carbazole compound. The preparation method of the N-substituted dibenzo[a,c]carbazole compound has fewer reaction steps, low cost of raw material, mild reaction conditions and convenient operation. Moreover, the obtained product has high yield and high purity, fully meets the quality requirements for drug intermediates, and provides favorable conditions for the industrial production. | 2020-08-20 |
20200262791 | QUINOLINE DERIVATIVE AND USE THEREOF AS TYROSINE KINASE INHIBITOR - A quinoline derivative compound shown in formula (II), a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to a tyrosine kinase inhibitor. | 2020-08-20 |
20200262792 | Co-Crystal of an Orally Available Hif Prolyl Hydroxylase Inhibitor - The present invention relates to a co-crystal of roxadustat with L-proline and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising said roxadustat L-proline co-crystal, at least one pharmaceutically acceptable excipient and optionally at least one photostabilizing agent. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment and/or prevention of anemia in patients with end-stage renal disease (ESRD) and/or chronic kidney disease (CKD). | 2020-08-20 |
20200262793 | Substituted Heterocyclyl Derivatives as CDK Inhibitors - The present invention provides substituted heterocyclylderivatives of formula (I), which are therapeutically useful, particularly as selective transcriptional CDK inhibitors including CDK7, CDK9, CDK12, CDK13 and CDK18, more particularly transcriptional CDK7 inhibitors. These compounds are useful in the treatment and prevention of diseases and/or disorders associated with selective transcriptional CDKs in a mammal. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the substituted heterocyclyl derivatives of formula (I) or a pharmaceutically acceptable salt or a stereoisomer thereof. | 2020-08-20 |
20200262794 | GLYCOLATE OXIDASE INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF KIDNEY STONES - Provided herein are compounds of Formula I and Formula II, and compositions comprising the same, as well as methods of use thereof for treating kidney stones (e.g., inhibiting the formation of oxalate kidney stones; treating primary hyperoxaluria), inhibiting the production of glyoxylate and/or oxalate, and/or inhibiting glycolate oxidase (GO). | 2020-08-20 |
20200262795 | CYANOPYRIMIDINE DERIVATIVES - The present invention relates to compounds of formula M | 2020-08-20 |
20200262796 | 6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - A compound represented by Formula (I): | 2020-08-20 |
20200262797 | Formation of N-Protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine - The disclosed embodiments detail improved methods for the synthesis of diketopiperazines from amino acids. In particular improved methods for the cyclocondensation and purification of N-protected 3,6-(aminoalkyl)-2,5-diketopiperazines from N-protected amino acids. Disclosed embodiments describe methods for the synthesis of 3,6-bis-[N-protected aminoalkyl]-2,5-diketopiperazine comprising heating a mixture of an amino acid in the presence of a catalyst in an organic solvent. The catalyst is selected from the group comprising sulfuric acid, phosphoric acid, p-toluenesulfonic acid, 1-propylphosphonic acid cyclic anhydride, tributyl phosphate, phenyl phosphonic acid and phosphorous pentoxide among others. The solvent is selected from the group comprising: dimethylacetamide, N-methyl-2-pyrrolidone, diglyme, ethyl glyme, proglyme, ethyldiglyme, m-cresol, p-cresol, o-cresol, xylenes, ethylene glycol and phenol among others. | 2020-08-20 |
20200262798 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME - The present invention relates to a compound represented by any one of the following formula A to formula C, and a photosensitive composition comprising the same, wherein the structure of the compound represented by any one of formula A to formula C is as described in the detailed description of the invention. | 2020-08-20 |
20200262799 | PROCESS FOR PREPARING FUNCTIONALIZED 1,2,4,5-TETRAZINE COMPOUNDS - The present invention relates to a process for the synthesis of 3,6 functionalized 1,2,4,5-tetrazine compounds. | 2020-08-20 |
20200262800 | HYDROGEN ISOTOPE-ENRICHED ANALOGUES OF 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS AND USES THEREOF - Novel hydrogen isotope-enriched 1,2,4-oxadiazole benzoic acid compounds, methods of their use and pharmaceutical compositions thereof are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination. | 2020-08-20 |
20200262801 | POLYMERIZABLE COMPOUND AND A PRODUCTION METHOD FOR SAME, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICAILLY ANISOTROPIC BODY, POLARIZING PLATE, DISPLAY DEVICE, ANTIREFLECTION FILM, AND COMPOUND AND USE FOR SAME - Disclosed is a polymerizable compound useful in the preparation of a polymer which is capable of producing, for example, an optical film having excellent in-plane thickness uniformity and improved in-plane uniformity in optical properties. The polymerizable compound of the present disclosure is represented by formula (I): | 2020-08-20 |
20200262802 | PHOTO-CROSSLINKED HYDROGEL MATERIAL AND PREPARATION, COMPOSITION, AND APPLICATION THEREOF PHOTO-CROSSLINKED HYDROGEL - This invention provides preparations, compositions, products, and applications of photo-crosslinked hydrogels. Component A—a photosensitive polymer derivative, component B—the photoinitiator, and auxiliary component C—other biocompatible polymer derivative each are respectively dissolved in a biocompatible medium to obtain solution A, solution B, and solution C. The solution A, the solution B, and the optional solution C are mixed homogenously to obtain a hydrogel precursor solution. The hydrogel precursor solution is subject to irradiation of the UV light for photocoupled crosslinking to form a photo-crosslinked hydrogel. The photo-crosslinked hydrogel exhibit rapid speed of photo-curing, strong tissue adhesion, excellent mechanical properties, good biocompatibility, and excellent clinical operability. In addition, this invention also provides a kit for making the photo-crosslinked hydrogel, and applications thereof in tissue engineering, regenerative medicine, 3D printing, and as a carrier of cell, protein, or drug. | 2020-08-20 |
20200262803 | PROCESS FOR SEPARATING FURANIC COMPOUNDS, IN PARTICULAR 5-HYDROXYMETHYLFURFURAL, FROM DIMETHOXYSULFOXIDE BY LIQUID-LIQUID EXTRACTIONS - The invention relates to a process for separating furanic compounds from a feedstock additionally containing dimethoxysulfoxide (DMSO). These furanic compounds are in particular 5-hydroxymethylfurfural (5-HMF), 2,5-diformylfuran (DFF), 2,5-furanedicarboxylic acid (FDCA) or dimethyl 2,5-furandicarboxylate (DMFDCA). The process successively comprises a) bringing the feedstock into contact with water originating from step c), then b) a liquid-liquid extraction with an organic solvent followed by a back extraction c) by the water added in order to obtain an organic extract rich in furanic compounds. The extract may then be subjected to a crystallization step d) and then a filtration in order to obtain the solid furanic compound. The water-rich or solvent-rich effluents are advantageously recycled respectively to the back extraction and the extraction. | 2020-08-20 |
20200262804 | Isotopically-Stabilized Tetronimide Compounds - Isotopically-stabilized tetronimide compounds comprising one or more deuterium atoms, derivatives, and intermediates, thereof, including methods for their synthesis, pharmaceutical compositions thereof, and methods of using these compounds to interact with target molecules in cell-free samples, cell- and tissue-based assays, animal models, and in a subject are disclosed. One aspect relates to molecules that modulate the expression or catalytic activity of aspartyl (asparaginyl) β-hydroxylase (ASPH) within or on the surface of a cell. Other aspects of the invention relate to use of the molecules disclosed herein to diagnose, ameliorate, or treat cell proliferation disorders and related diseases. Related aspects include uses of the compounds to modulate the activity of viruses, as anti-hyperlipidemia agents, and as agents to ameliorate or treat thrombosis and related cardiovascular and metabolic disorders. | 2020-08-20 |
20200262805 | HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES - The present invention relates to novel compounds, particularly to hydrophilic compounds, comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices. The present application also relates to ophthalmic devices comprising such compounds. | 2020-08-20 |
20200262806 | METHOD FOR SYNTHESIS OF CANNABIS PRODUCTS - The present invention provides methods of extraction of at least one cannabinoid from an initial | 2020-08-20 |
20200262807 | XANTHENE-BASED COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION COMPRISING SAME - The present specification provides a compound represented by Chemical Formula 1, a colorant composition, a resin composition, a photosensitive material, a color filter and a display device comprising the same. | 2020-08-20 |
20200262808 | DIBENZOTHIOPHENE COMPOUNDS - The present invention generally relates to various dibenzothiophene compounds, processes for preparing these compounds, and uses of these compounds. The present invention also relates to cell imaging agents comprising one or more of the dibenzothiophene compounds and processes for imaging a cell using the compounds. The present invention further relates to methods of producing ground state atomic oxygen. | 2020-08-20 |
20200262809 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS AND SKIN DISEASES - Disclosed is a compound of formula I or a pharmaceutically acceptable hydrate, solvate, crystal, co-crystal, enantiomer, stereoisomer, polymorph or prodrug thereof, which is useful for treatment of eye disorders, skin diseases and/or complications associated therewith. Also disclosed is a pharmaceutical composition comprising as an active ingredient at least one compound of formula I and a pharmaceutically acceptable excipient. Also disclosed is a method of treating an eye disorder, skin disease and/or a complication thereof in a subject in need thereof by administering at least one compound of formula I or a pharmaceutically acceptable hydrate, solvate, crystal, co-crystal, enantiomer, stereoisomer, polymorph or prodrug thereof. | 2020-08-20 |
20200262810 | CRYSTALLINE 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE MONOHYDRATE, COMPOSITIONS AND METHODS OF USE THEREOF - Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate. Pharmaceutical compositions comprising the crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate are also disclosed. | 2020-08-20 |
20200262811 | Quinazoline Derivatives as VEGF Inhibitors - The invention relates to quinazoline derivatives of formula (I), wherein m is an integer from 1 to 3; R | 2020-08-20 |
20200262812 | 4, 5, 6-TRI-SUBSTITUTED INDAZOLES DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN MEDICINES - Provided are 4,5,6-tri-substituted indazoles derivatives, a preparation method therefor, and a use thereof in medicines. Specifically, provided are compounds of formula (I) or pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs thereof, a preparation method therefor, and a use thereof. | 2020-08-20 |
20200262813 | 1,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES - The present disclosure relates to 1,5,7-trisubstituted isoquinoline derivatives, their preparation and pharmaceutical use. In particular, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof. The definitions of the groups in the formula can be found in the specification and claims. | 2020-08-20 |
20200262814 | PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE - PKC inhibitors are disclosed. The PKC inhibitors are useful for treating PKC associated diseases, including certain cancers. The PKC inhibitors have improved efficacy at lower dosage amounts to achieve tumor regression, improved potency, PK profile, absorption, gastrointestinal tolerance and kinase selectivity. | 2020-08-20 |
20200262815 | THERAPEUTIC COMPOUNDS - The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): | 2020-08-20 |
20200262816 | ISOINDOLINE OR ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Compound of formula (I): | 2020-08-20 |
20200262817 | AMINO PYRIMIDINE SSAO INHIBITORS - The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds, | 2020-08-20 |
20200262818 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS - Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement. | 2020-08-20 |
20200262819 | BENZOIMIDAZOLE INDOLYL METHANES AND METHODS OF USING THEM TO INHIBIT PCKS9 AND PCKS9-MEDIATED AILMENTS - Described are benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and use of the compounds to inhibit PCSK9-mediated ailments. The compounds have the structure: | 2020-08-20 |
20200262820 | PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof. | 2020-08-20 |
20200262821 | PROCESS FOR THE PREPARATION OF PAZOPANIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - The present invention is relates to an improved process for the preparation of pazopanib or a pharmaceutically acceptable salts thereof. The present invention also relates to novel polymorphic Forms of pazopanib hydrochloride, and its intermediates thereof, | 2020-08-20 |
20200262822 | Anti-Proprotein Convertase Subtilisin Kexin Type 9 (Anti-PCSK9) Compounds and Methods of Using the Same in the Treatment and/or Prevention of Cardiovascular Diseases - Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (PCSK9), as well as therapeutic methods for use of such compounds to reduce LDL-cholesterol levels and/or for the treatment and/or prevention of cardiovascular disease (CVD), including treatment of hypercholesterolemia. | 2020-08-20 |
20200262823 | METHODS OF TREATING CANCER - The present invention relates to methods of treating cancer by administering the EZH2 inhibitor compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes. | 2020-08-20 |
20200262824 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES - Compounds of the formula (I) wherein the substituents are as defined in claim | 2020-08-20 |
20200262825 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME - Provided is a novel heterocyclic compound of Chemical Formula 1: | 2020-08-20 |
20200262826 | HETEROARYL ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS - The present disclosure relates to compounds of formula I that are useful as modulators of 7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation (I). | 2020-08-20 |
20200262827 | AROMATIC DERIVATIVE, PREPARATION METHOD FOR SAME, AND MEDICAL APPLICATIONS THEREOF - An aromatic derivative as represented by formula (I), a pharmaceutically acceptable salt thereof or a pharmaceutical composition comprising same, a preparation method therefor, and uses of the aromatic derivative and the pharmaceutically acceptable salt thereof or the pharmaceutical composition comprising same in preparing a therapeutic agent, specifically an FGFR4 tyrosine kinase inhibitor, and in preparing a medicament for treating and/or preventing neoplastic and inflammatory diseases. The substituents of formula (I) are same as defined in the description. | 2020-08-20 |
20200262828 | COMPOUNDS AND USES THEREOF - The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders. | 2020-08-20 |
20200262829 | Novel Compounds for Imaging Tau Proteins That Accumulate in the Brain - The present invention provides a compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, or a solvate thereof. | 2020-08-20 |
20200262830 | NOVEL (CYANO-DIMETHYL-METHYL)-ISOXAZOLES AND -[1,3,4]THIADIAZOLES - This invention relates to novel (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles and their use as CB2 cannabinoid receptor agonists, pharmaceutical compositions containing the same, and their use for the treatment of CB2 receptor mediated disorders or conditions. | 2020-08-20 |
20200262831 | Factor XIIa Inhibitors - The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIIa inhibitors. | 2020-08-20 |
20200262832 | URAT1 INHIBITOR FOR PROMOTING URIC ACID EXCRETION - The present invention belongs to the field of medicinal chemistry. Specifically disclosed is a class of URAT1 inhibitors for promoting uric acid excretion, which are compounds as represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on the transport of uric acid by hURAT1 in HEK293 transfected cells, and that such compounds have a good application prospect in the treatment of hyperuricemia or gout. | 2020-08-20 |
20200262833 | DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES - The present invention provides, in part, compounds of Formula I, or an N-oxide thereof, or a pharmaceutically acceptable salt of the compound or the N-oxide, wherein: (R | 2020-08-20 |
20200262834 | [9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO-[2,1-A]IS- OQUINOLIN-2-YL]METHANOL AND COMPOUNDS, COMPOSITIONS AND METHODS RELATING THERETO - Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: | 2020-08-20 |
20200262835 | COMPOUNDS - Compound of formula (I) or a pharmaceutically acceptable salt, or N-oxide thereof, that are inhibitors of SSAO activity: | 2020-08-20 |
20200262836 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION - The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 2020-08-20 |